Cargando…

Identification of Novel HLA Class II-Restricted Neoantigens Derived from Driver Mutations

Neoantigens derived from tumor-specific genetic mutations might be suitable targets for cancer immunotherapy because of their high immunogenicity. In the current study, we evaluated the immunogenicity of 10 driver mutations that are frequently expressed in various cancers using peripheral blood mono...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iiizumi, Susumu, Ohtake, Junya, Murakami, Naoko, Kouro, Taku, Kawahara, Mamoru, Isoda, Fumiko, Hamana, Hiroshi, Kishi, Hiroyuki, Nakamura, Norihiro, Sasada, Tetsuro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406322/ https://www.ncbi.nlm.nih.gov/pubmed/30813491 http://dx.doi.org/10.3390/cancers11020266

Ejemplares similares

Exhaustion of CAR T cells: potential causes and solutions
por: Kouro, Taku, et al.
Publicado: (2022)

Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens
por: Hwang, Michael S., et al.
Publicado: (2021)

Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer
por: Aparicio, Belén, et al.
Publicado: (2022)

Immune Responses to Epidermal Growth Factor Receptor (EGFR) and Their Application for Cancer Treatment
por: Sasada, Tetsuro, et al.
Publicado: (2016)

HLA class-I and class-II restricted neoantigen loads predict overall survival in breast cancer
por: Ren, Yingxue, et al.
Publicado: (2020)

Identification of HLA-A2-Restricted Mutant Epitopes from Neoantigens of Esophageal Squamous Cell Carcinoma
por: Wang, Zhiwei, et al.
Publicado: (2021)

Generation of TGFβR2(-1) neoantigen-specific HLA-DR4-restricted T cell receptors for cancer therapy
por: Plewa, Natalia, et al.
Publicado: (2023)

P1254: BASELINE HLA-DR-RESTRICTED NEOANTIGEN BURDEN OF AML BLASTS IMPACTS ON HLA-DR GENE EXPRESSION AT RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANT
por: Charrot, Sarah, et al.
Publicado: (2023)

Elevated neoantigen levels in tumors with somatic mutations in the HLA-A, HLA-B, HLA-C and B2M genes
por: Castro, Andrea, et al.
Publicado: (2019)

Hepatobiliary Tumor Organoids Reveal HLA Class I Neoantigen Landscape and Antitumoral Activity of Neoantigen Peptide Enhanced with Immune Checkpoint Inhibitors
por: Wang, Wenwen, et al.
Publicado: (2022)

Identification of a novel HLA-A24-restricted cytotoxic T lymphocyte epitope peptide derived from mesothelin in pancreatic cancer
por: Tsukagoshi, Mariko, et al.
Publicado: (2018)

Evaluation of X-ray and carbon-ion beam irradiation with chemotherapy for the treatment of cervical adenocarcinoma cells in 2D and 3D cultures
por: Sekihara, Kazumasa, et al.
Publicado: (2022)

Multi-step screening of neoantigens’ HLA- and TCR-interfaces improves prediction of survival
por: Richard, Guilhem, et al.
Publicado: (2021)

Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment
por: Newey, Alice, et al.
Publicado: (2019)

Fetal Lymphoid Progenitors Become Restricted to B-1 Fates Coincident with IL-7Rα Expression
por: Iida, Ryuji, et al.
Publicado: (2016)

Immune mediators as predictive biomarkers for anti-PD-1 antibody therapy in urothelial carcinoma
por: Shibata, Yosuke, et al.
Publicado: (2023)

Beyond Neoantigens: Antigens Derived from Tumor Drivers as Cancer Vaccine Targets
por: Crosby, Erika J., et al.
Publicado: (2023)

NeoFox: annotating neoantigen candidates with neoantigen features
por: Lang, Franziska, et al.
Publicado: (2021)

Creating MHC-Restricted Neoantigens with Covalent Inhibitors That Can Be Targeted by Immune Therapy
por: Hattori, Takamitsu, et al.
Publicado: (2023)

Lymphoma neoantigens
por: Elias, Joshua E.
Publicado: (2018)

Targeting Driver Oncogenes and Other Public Neoantigens Using T Cell Receptor–Based Cellular Therapy
por: Martinov, Tijana, et al.
Publicado: (2023)

Proteogenomic identification of an immunogenic HLA class I neoantigen in mismatch repair–deficient colorectal cancer tissue
por: Hirama, Tomomi, et al.
Publicado: (2021)

Dominant neoantigen verification in hepatocellular carcinoma by a single-plasmid system coexpressing patient HLA and antigen
por: Chen, Pu, et al.
Publicado: (2023)

A Bidirectional Versatile Buck–Boost Converter Driver for Electric Vehicle Applications
por: González-Castaño, Catalina, et al.
Publicado: (2021)

HLA-A24-restricted HTLV-I-specific CTL response reduces the HTLV-I proviral load but the HLA increases the risk of HAM/TSP
por: Kubota, Ryuji, et al.
Publicado: (2011)

Differential ion mobility mass spectrometry in immunopeptidomics identifies neoantigens carrying colorectal cancer driver mutations
por: Minegishi, Yuriko, et al.
Publicado: (2022)

DeepHLApan: A Deep Learning Approach for Neoantigen Prediction Considering Both HLA-Peptide Binding and Immunogenicity
por: Wu, Jingcheng, et al.
Publicado: (2019)

Identification of patient-specific CD4(+) and CD8(+) T cell neoantigens through HLA-unbiased genetic screens
por: Cattaneo, Chiara M., et al.
Publicado: (2023)

Machine learning for prediction of immunotherapeutic outcome in non-small-cell lung cancer based on circulating cytokine signatures
por: Wei, Feifei, et al.
Publicado: (2023)

Determinants for Neoantigen Identification
por: Garcia-Garijo, Andrea, et al.
Publicado: (2019)

Neoantigens in Hematologic Malignancies
por: Biernacki, Melinda A., et al.
Publicado: (2020)

An HLA-A*11:01-Binding Neoantigen from Mutated NPM1 as Target for TCR Gene Therapy in AML
por: van der Lee, Dyantha I., et al.
Publicado: (2021)

Generation of novel complete HLA class I monoallelic cell lines used in an MHC stabilization assay for neoantigen evaluation
por: Iizuka, Akira, et al.
Publicado: (2023)

EGFR T790M Mutation as a Possible Target for Immunotherapy; Identification of HLA-A*0201-Restricted T Cell Epitopes Derived from the EGFR T790M Mutation
por: Yamada, Teppei, et al.
Publicado: (2013)

Development of antigen‐prediction algorithm for personalized neoantigen vaccine using human leukocyte antigen transgenic mouse
por: Charneau, Jimmy, et al.
Publicado: (2022)

HLA class I loss in metachronous metastases prevents continuous T cell recognition of mutated neoantigens in a human melanoma model
por: Schrörs, Barbara, et al.
Publicado: (2017)

Characterization of CD8(+) T-cell responses to non-anchor-type HLA class I neoantigens with single amino-acid substitutions
por: Shinkawa, Tomoyo, et al.
Publicado: (2021)

Identifying neoantigens for use in immunotherapy
por: Hutchison, Sharon, et al.
Publicado: (2018)

Main Strategies for the Identification of Neoantigens
por: Gopanenko, Alexander V., et al.
Publicado: (2020)

The Neoantigen Landscape of Mycosis Fungoides
por: Sivanand, Arunima, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m0ge348v67rgv3u7q05i3k5r7v